上海瑞齊生物科技有限公司作者
Rabbit Anti- Syndecan-1/CD138
資料類型 | 文件 | 資料大小 | |
下載次數 | 0 | 資料圖片 | 【點擊查看】 |
上 傳 人 | 上海瑞齊生物科技有限公司 | 需要積分 | 0 |
關 鍵 詞 | Rabbit Anti-Syndecan-1/CD138,Anti-CD138 |
- 【資料簡介】
Rabbit Anti- Syndecan-1/CD138
Catalog Number : RS-1309R
Quantity size : 0.1ml (dilute with pH 7.4 0.01 M PBS or antibody diluent )
Background: CD138 / Syndecan 1 is a transmembrane heparin sulphate proteoglycan which is made up of one core protein and five glycosaminoglycan. CD138 is expected to play a role in cell adhesion. It is expressed on the surface of pre B cells and plasma cells but is absent from mature B cells. It is a selective marker for B cell lymphoblastic leukemia and lymphoplasmocytoid leukemia. It is lost from the apoptotic myeloma cells; hence is a useful marker for viable myeloma cells.
Specificity : • anti-CD138 is a Rabbit polyclonal antibody unconjugated
•specific for CD138 of human, mo, rat, dog
•epitope mapping near the N-terminus of CD138 of human, mo, rat, dog
•use for western blotting, elisa, immunoprecipitation
and immunohistochemistry
• Protein G affinity chromatography purification, purity :>95%
• Isotype: IgG
Application: •Western blotting 1:100-500
• Immunohistochemistry 1:100-500
•ELISA 1:500-1000
• Optimal working dilutions must be determined by the end user.
Storage: Store at –20 ºC for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20ºC. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody, the antibody is stable for at least two weeks at 2-4 ºC.
Important Note: This product as supplied is intended for research use only, not for use in
human, therapeutic or diagnostic applications.
- 凡本網注明"來源:環保在線"的所有作品,版權均屬于環保在線,轉載請必須注明環保在線,http://www.jxtpzs.com。違反者本網將追究相關法律責任。
- 企業發布的公司新聞、技術文章、資料下載等內容,如涉及侵權、違規遭投訴的,一律由發布企業自行承擔責任,本網有權刪除內容并追溯責任。
- 本網轉載并注明自其它來源的作品,目的在于傳遞更多信息,并不代表本網贊同其觀點或證實其內容的真實性,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時,必須保留本網注明的作品來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發表之日起一周內與本網聯系,否則視為放棄相關權利。